Log In
Print
BCIQ
Print
Print this Print this
 

QAW039

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionProstaglandin D2 (PGD2) receptor (CRTH2; GPR44; CD294) antagonist
Molecular Target Prostaglandin D2 (PGD2) receptor subtype DP2 (PTGDR2) (CRTH2) (GPR44) (DP2)
Mechanism of ActionProstaglandin D2 (PGD2) receptor subtype DP2 (CRTH2) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today